CHSCN Fundamental Analysis - CHS INC - CHSINC 7.1 PERP

Fundamental Rating

Taking everything into account, CHSCN scores 3 out of 10 in our fundamental rating. CHSCN was compared to 88 industry peers in the Food Products industry. CHSCN has a medium profitability rating, but doesn't score so well on its financial health evaluation. CHSCN is valued expensive and it does not seem to be growing. Finally CHSCN also has an excellent dividend rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CHSCN had a positive cash flow from operations.

Each year in the past 5 years CHSCN has been profitable.

CHSCN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of CHSCN (2.61%) is comparable to the rest of the industry.

The Return On Equity of CHSCN (4.76%) is comparable to the rest of the industry.

CHSCN's Return On Invested Capital of 0.05% is in line compared to the rest of the industry. CHSCN outperforms 40.91% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for CHSCN is significantly below the industry average of 28.74%.

The last Return On Invested Capital (0.05%) for CHSCN is well below the 3 year average (6.11%), which needs to be investigated, but indicates that CHSCN had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	2.61%
ROE	4.76%
ROIC	0.05%

ROA(3y)8.28%

ROA(5y)6.12%

ROE(3y)15.4%

ROE(5y)11.43%

ROIC(3y)6.11%

ROIC(5y)4.27%

1.3 Margins

CHSCN has a Profit Margin (1.42%) which is in line with its industry peers.

In the last couple of years the Profit Margin of CHSCN has grown nicely.

Looking at the Operating Margin, with a value of 0.02%, CHSCN is in line with its industry, outperforming 40.91% of the companies in the same industry.

CHSCN's Operating Margin has declined in the last couple of years.

The Gross Margin of CHSCN (2.99%) is worse than 87.50% of its industry peers.

In the last couple of years the Gross Margin of CHSCN has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	0.02%
PM (TTM)	1.42%
GM	2.99%

OM growth 3Y40.55%

OM growth 5Y-6.01%

PM growth 3Y24.89%

PM growth 5Y1.53%

GM growth 3Y21.71%

GM growth 5Y0.55%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCN is still creating some value.

The debt/assets ratio for CHSCN is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.22 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Altman-Z score of CHSCN (2.22) is comparable to the rest of the industry.

CHSCN has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.34, CHSCN is in the better half of the industry, outperforming 61.36% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.34
Debt/FCF	N/A
Altman-Z	2.22

ROIC/WACC0.01

WACC4.7%

2.3 Liquidity

A Current Ratio of 1.40 indicates that CHSCN should not have too much problems paying its short term obligations.

With a Current ratio value of 1.40, CHSCN perfoms like the industry average, outperforming 47.73% of the companies in the same industry.

CHSCN has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.86, CHSCN is in line with its industry, outperforming 46.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.4
Quick Ratio	0.86

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Revenue has decreased by -8.96% in the past year.

Measured over the past years, CHSCN shows a small growth in Revenue. The Revenue has been growing by 4.24% on average per year.

EPS 1Y (TTM)N/A

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)-8.96%

Revenue growth 3Y0.7%

Revenue growth 5Y4.24%

Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

94.32% of the companies in the same industry are more expensive than CHSCN, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	3.76

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.00%, CHSCN is a good candidate for dividend investing.

Compared to an average industry Dividend Yield of 4.66, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 90.91% of the companies listed in the same industry.

CHSCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.

		Industry Rank	Sector Rank
Dividend Yield	7%

5.2 History

CHSCN has paid a dividend for at least 10 years, which is a reliable track record.

CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years10

5.3 Sustainability

CHSCN pays out 32.94% of its income as dividend. This is a sustainable payout ratio.

DP32.94%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (9/11/2025, 4:30:01 PM)

25.41

0 (-0.02%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)07-09 2025-07-09

Earnings (Next)11-04 2025-11-04

Inst Owners11.3%

Inst Owner Change-91.8%

Ins Owners0.03%

Ins Owner ChangeN/A

Market Cap311.78M

Analysts0

Price TargetN/A

Short Float %0.29%

Short Ratio1.18

Dividend

		Industry Rank	Sector Rank
Dividend Yield	7%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP32.94%

Div Incr Years0

Div Non Decr Years10

Ex-Date06-13 2025-06-13 (0.44375)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.01
P/FCF	N/A
P/OCF	0.65
P/B	0.03
P/tB	0.03
EV/EBITDA	3.76

EPS(TTM)N/A

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-26.32

FCFYN/A

OCF(TTM)38.96

OCFY153.31%

SpS2936.43

BVpS878.97

TBVpS878.97

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	2.61%
ROE	4.76%
ROCE	0.07%
ROIC	0.05%
ROICexc	0.05%
ROICexgc	0.05%
OM	0.02%
PM (TTM)	1.42%
GM	2.99%
FCFM	N/A

ROA(3y)8.28%

ROA(5y)6.12%

ROE(3y)15.4%

ROE(5y)11.43%

ROIC(3y)6.11%

ROIC(5y)4.27%

ROICexc(3y)6.66%

ROICexc(5y)4.61%

ROICexgc(3y)6.79%

ROICexgc(5y)4.69%

ROCE(3y)8.06%

ROCE(5y)5.71%

ROICexcg growth 3Y38.36%

ROICexcg growth 5Y-3.28%

ROICexc growth 3Y37.82%

ROICexc growth 5Y-3.23%

OM growth 3Y40.55%

OM growth 5Y-6.01%

PM growth 3Y24.89%

PM growth 5Y1.53%

GM growth 3Y21.71%

GM growth 5Y0.55%

F-Score3

Asset Turnover1.83

Health

		Industry Rank	Sector Rank
Debt/Equity	0.34
Debt/FCF	N/A
Debt/EBITDA	5.94
Cap/Depr	131.31%
Cap/Sales	2.22%
Interest Coverage	250
Cash Conversion	77.22%
Profit Quality	N/A
Current Ratio	1.4
Quick Ratio	0.86
Altman-Z	2.22

F-Score3

WACC4.7%

ROIC/WACC0.01

Cap/Depr(3y)104.21%

Cap/Depr(5y)89.6%

Cap/Sales(3y)1.35%

Cap/Sales(5y)1.27%

Profit Quality(3y)93.36%

Profit Quality(5y)103.6%

High Growth Momentum

Growth

EPS 1Y (TTM)N/A

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-8.96%

Revenue growth 3Y0.7%

Revenue growth 5Y4.24%

Sales Q2Q%1.63%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-98.83%

EBIT growth 3Y41.53%

EBIT growth 5Y-2.03%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-109.49%

FCF growth 3Y1.79%

FCF growth 5Y-7.81%

OCF growth 1Y-87.82%

OCF growth 3Y18.88%

OCF growth 5Y2.23%

CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens